Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

Valerie Bandy of Tecsys on where 340B rebate mechanics threaten pharmacy purchasing, and how stakeholders can prevent disruption. In the third and final installment of Pharmaceutical Commerce’s video ...

DSCSA compliance is no longer a live question for most trading partners, but two new work streams, the shift to a 12-digit ...

CMS says 40 states and Puerto Rico have signed on to the GENEROUS Model, which applies MFN pricing to Medicaid drugs through state-invoiced rebates. The Centers for Medicare & Medicaid Services (CMS) ...

The EU's pharma reform makes market protection more conditional. Here is how US drugmakers, especially startups, can adapt and use IP to complement it. The European Union's (EU) pharmaceutical reform ...

In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk ...

As pharmaceutical companies move AI into patient access and support operations, most still rely on manual sampling and ...

Leadership Summit will return to CPHI Milan, which runs Oct. 6-8 in Milan, Italy, as manufacturers face mounting pressu ...

Liberty Dewey of Cardinal Health breaks down the NDC-12 transition timeline, the four work streams driving it and why the ...

Legislative paths for GENEROUS, GLOBE, and GUARD remain blocked by intra-party resistance and intensifying midterm dynamics, ...

In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds ...

In the final installment of his interview with Pharmaceutical Commerce, Cencora's Gregg Gorniak looks back at DSCSA's ...